Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Authors
Keywords
Drug metabolism, Cholesterol, Genetics, Drug discovery, Lipoproteins, Coronary heart disease, Genome-wide association studies, Lipid metabolism
Journal
PLOS BIOLOGY
Volume 20, Issue 2, Pages e3001547
Publisher
Public Library of Science (PLoS)
Online
2022-02-26
DOI
10.1371/journal.pbio.3001547
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indication
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Causal inference for heritable phenotypic risk factors using heterogeneous genetic instruments
- (2021) Jingshu Wang et al. PLoS Genetics
- A transcriptome-wide Mendelian randomization study to uncover tissue-dependent regulatory mechanisms across the human phenome
- (2020) Tom G. Richardson et al. Nature Communications
- Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
- (2020) Tom G. Richardson et al. PLOS MEDICINE
- The next generation of triglyceride-lowering drugs
- (2020) Laurens F. Reeskamp et al. CURRENT OPINION IN LIPIDOLOGY
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis
- (2020) Qin Wang et al. EUROPEAN HEART JOURNAL
- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
- (2019) Eeva Sliz et al. CIRCULATION
- What is ‘LDL cholesterol’?
- (2019) Michael V. Holmes et al. Nature Reviews Cardiology
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- (2019) Jane Armitage et al. LANCET
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can Mendelian Randomization Shift into Reverse Gear?
- (2019) Michael V. Holmes et al. CLINICAL CHEMISTRY
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition
- (2019) Johannes Kettunen et al. PLOS BIOLOGY
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia
- (2018) Joel Schmitz et al. CURRENT MEDICINAL CHEMISTRY
- A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease
- (2018) Pedrum Mohammadi-Shemirani et al. CLINICAL CHEMISTRY
- Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile
- (2018) Lisanne L. Blauw et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings
- (2018) Eleanor Sanderson et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The UK Biobank resource with deep phenotyping and genomic data
- (2018) Clare Bycroft et al. NATURE
- Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
- (2018) Anubha Mahajan et al. NATURE GENETICS
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
- (2016) Peter Würtz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
- (2016) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both
- (2015) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
- (2015) Majid Nikpay et al. NATURE GENETICS
- Efficient Bayesian mixed-model analysis increases association power in large cohorts
- (2015) Po-Ru Loh et al. NATURE GENETICS
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods
- (2015) Stephen Burgess et al. STATISTICS IN MEDICINE
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
- (2015) Cathie Sudlow et al. PLOS MEDICINE
- Mendelian randomization of blood lipids for coronary heart disease
- (2014) Michael V. Holmes et al. EUROPEAN HEART JOURNAL
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
- (2013) Stephen Burgess et al. GENETIC EPIDEMIOLOGY
- ggplot2: Elegant Graphics for Data Analysis
- (2011) Cedric Ginestet JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now